Form 8-K/A - Current report: [Amend]
SEC Accession No. 0000886163-18-000044
Filing Date
2018-03-07
Accepted
2018-03-07 06:03:09
Documents
1
Period of Report
2018-03-06
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 7.01: Regulation FD Disclosure
Item 8.01: Other Events

Document Format Files

Seq Description Document Type Size
1 8-K/A graamended8k-3718.htm 8-K/A 28214
  Complete submission text file 0000886163-18-000044.txt   29389
Mailing Address 3911 SORRENTO VALLEY BLVD SUITE 110 SAN DIEGO CA 92121
Business Address 3911 SORRENTO VALLEY BLVD SUITE 110 SAN DIEGO CA 92121 858-550-7500
LIGAND PHARMACEUTICALS INC (Filer) CIK: 0000886163 (see all company filings)

EIN.: 770160744 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K/A | Act: 34 | File No.: 001-33093 | Film No.: 18671830
SIC: 2834 Pharmaceutical Preparations